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Abstract
Background: The goal of this research was to measure the age-sex standard-
ized prevalence of pre-diabetes (pre-DM) and diabetes (DM), and the effec-
tiveness of diabetes management (using HbA1C as the indicator) in an urban
area in Iran.
Methods: Using a randomized cluster household survey, we recruited 5900
individuals whose age ranged from 15 to 75 from Kerman for assessing
coronary artery disease risk factors (KERCADRS) including diabetes. In
2010 and 2011, all of the participants were interviewed by trained staff for
medical history and physical activities, and were then examined for blood
pressure and anthropometric measures. Venus blood sample was also col-
lected for fasting plasma glucose and HbA1c.
Results: The age-sex standardized prevalence of pre-diabetes, diagnosed and
undiagnosed was 18.7%, 6.3% and 2.7%, respectively. Diabetes increased by
age (from 14.7% in the 15–24 years old group to 28.4% in the 65–75 years old
group), particularly after 40 years. Occasional opium users had the highest
prevalence of Pre-DM (34.6%). Seventy-nine percent of the depressed and
75.5% of the anxious participants with diagnosed-DM were identified as
uncontrolled-DM. More than 60% of diagnosed diabetic cases had impaired
HbA1c. Overweight and obesity (adjusted odds ratio (AOR) 1.6) and low
physical activity (AOR 1.5) were the most preventable risk factors associated
with diabetes.
Conclusion: Considerable prevalence of diabetes, susceptibility in progress-
ing to diabetes and uncontrolled diabetes among individuals living in
Kerman, suggested ineffective prevention and treatment of diabetes in urban
areas in Iran. Successful experience regarding primary health-care in rural
areas should be expanded to urban settings.
Keywords: diabetes mellitus, diabetes treatment, HbA1c, Iran, pre-diabetes,
uncontrolled diabetes, undiagnosed diabetes.
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Introduction
The diabetes pandemic will increase from 175 million
patients with diabetes in 2000 to 353 million in 2030.1 It
is an important contributor to the burden of diseases,
particularly in developing countries.2
According to the national coronary artery disease
(CAD) risk factors surveillance report, the overall preva-
lence of diabetes in Iran is estimated to be 8.7% in adults
aged 15–64 years, of whom half (4.1%) were the newly
diagnosed cases.3 Based on a systematic review, the
prevalence of type 2 diabetes in Iran was estimated as
one out of four among adults aged ≥40.4However, it is
not clear how many are at pre-diabetes stage and are
prone to suffer from diabetes, or vice versa, with timely
interventions, the disease can be prevented.
In addition to late diagnosis, diabetes management is
another big challenge in Iran since only 39.2% of indi-
viduals with diagnosed diabetes in Iran receive treat-
ment.5 Using fasting plasma glucose (FPG) ≥7.2 mmol/L
the criteria for poor management of diabetes, about 57%
of individuals with diagnosed diabetes had high level of
plasma glucose.6
In this paper, we reported the age-sex standardized
prevalence of diabetes at all stages including pre-diabetes
(pre DM) and diabetes (DM). The research participants
were between 15 to 75 years of age, and they lived in an
urban setting in southeastern Iran, in Kerman. We also
assessed the effectiveness of diabetes management (using
HbA1C as the indicator) in people with diagnosed
diabetes. The prevalence of main related CAD
co-morbidities was also observed in pre-diabetic, diag-
nosed, undiagnosed and normal subpopulation.
Methods
The Kerman Coronary Artery Disease Risk Factors
(KERCADR) Study is a population based cohort study
with repeated surveys. In 2010–2011, 5900 individuals
aged between 15 and 75 years recruited into the first
round of the study. The subjects were recruited through
a non-proportional to size one-stage cluster sampling
household survey. The methodology of KERCADR
study has been explained in detail elsewhere.7Only those
who were able and provided written informed consent
were recruited into the study. The study protocol was
approved by the Ethical committee of Kerman Univer-
sity of Medical Sciences, Iran (Permission No.
88/110KA).
Interview and measurements
All details of the measurement are presented elsewhere.7
In brief, the trained interviewers assessed the study sub-
jects for different CAD risk factors using a structural
questionnaire. Part of the questionnaire that we used in
this study included demographic information, cigarette
smoking (yes/no), opium addiction (no/occasional/
dependent), the level of physical activity (low/moderate/
high), and the level of depression and anxiety (related
BECK questionnaires). The subjects were asked about
their past medical history and familial history of DM,
and whether they were under insulin or non-insulin
treatment.
Physical activity was determined by the Global Physi-
cal Activity Questionnaire, and Metabolic Equivalents
were used to express the intensity of physical activities.
Hypertension was defined as systolic blood pressure
≥140 mmHg and/or diastolic blood pressure ≥90 mmHg,
and/or taking any antihypertensive drugs. Overweight
was defined as body mass index (BMI) between 25 to
29.9 kg/m2 and obesity as BMI ≥30 kg/m2.
Every individual with previously diagnosed diabetes
(by a physician) and/or taking insulin or non-insulin
drugs and/or FPG ≥7 mmol/L at the time of recruitment
was considered a diabetic case. Others with FPG
between 5.6–6.9 mmol/L were considered as pre-diabetes
(pre-DM) cases. Subjects who had no previous history of
diabetes or anti-diabetic medication, but turned out to
have FPG ≥7 mmol/L at the recruitment were considered
as undiagnosed diabetic cases.
To determine the glycemic control status of diagnosed
diabetic patients, we tested every diabetic case for hemo-
globin A1c (HbA1c). Here we reported the uncontrolled
diabetes in both old and new definitions. In the old defi-
nition, uncontrolled diabetes was specified as HbA1c
>53 mmol/mol (>7%) for all individuals. However, based
Significant findings of the study: We found that diabetes and susceptibility in to diabetes was very common in
Kerman. The prevalence increased by age, particularly after 40 years. Depression and anxiety are very common in
uncontrolled diabetic patients in Iran.
What this study adds: A considerable number of people had their diabetes undiagnosed, while in those who have
been diagnosed for diabetes, the treatment was not effective and more than 60% presented with impaired HbA1c
test results.
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on the new definition, the cut-off is adjusted according to
the patients’ condition (American Diabetes Association,
2013).8Therefore, in those with onset or progression of
early stage microvascular and chronic complications,
and those aged more than 70 years HbA1c >64 mmol/
mol (>8%) was considered as the cut-off for poor glyce-
mic control (uncontrolled DM).
Laboratory measurements
All participants were asked not to eat for 12–14 h before
coming to the clinic. The blood samples were obtained
between 07.00 and 09.00 h, and FPG was measured
(KIMIA Kit, Code 890410, Iran). Subjects who had
FPG more than 5.6 mmol/L were recalled for another
FPG test and HbA1c test (NYCOCARD Kit, Code
1042184, Austria). To measure serum lipid profiles, total
cholesterol (KIMIA Kit, Code 890303, Iran) and triglyc-
erides (KIMIA Kit, Code 890201, Iran) were also mea-
sured for all individuals.
Statistical analysis
All statistical analyses were conducted under survey data
analysis using STATAv.12 (StataCorp, 2011 College
Station, TX, USA). For age-sex direct standardizations,
we used Kerman population reported in census 2006. All
prevalence rates were weighted according to the sam-
pling weight (reciprocal of the probability of selection)
and individual response rate. The data were presented as
absolute and relative frequencies as well as 95% confi-
dence intervals (95% CI). Univariate and multivariate
logistic regression models were applied to determine the
predictors of diabetes (both diagnosed and undiagnosed
DM). Crude and adjusted odds ratios (AOR) were also
reported.
Results
Demographic characteristics
The 5895 people recruited in this study were on average
45.4 (SD 16.4) years old and 54.9% were female. Accord-
ing to a self-report, 14.0% had never been to school and
a majority had not completed secondary education
(67.1%).
Pre-DM prevalence
Overall, the age- and sex-standardized prevalence of pre-
diabetes (Pre-DM) was 18.7% (men 23.4% vs women
13.7%) (Table 1). The Pre-DM prevalence constantly
increased from 14.7% in young adults (age group 15–24
years) to 28.4% in elderly people (age group 65–75 years).
One-quarter (25.9%) of the illiterate people had Pre-DM
status, which decreased to 18.0% in people with primary
to high school education. Pre-DM was more common
among non-smokers (11.5% vs 18.8%). Regarding opium
addiction, those who were reported to have occasional
use of opium had the highest prevalence of Pre-DM
(34.6%). Pre-DM prevalence was identified in 15.2% of
the depressed people and 18.4% in those with anxiety
symptoms. 16.1% of people with normal BMI had Pre-
DM, which increased to 22.1% in overweight and 20.1%
in obese people. The Pre-DM prevalence constantly
decreased from 20.5% in less physically active to 15.2%
in highly physically active people. Having familial
history of DM increased the prevalence of Pre-DM to
19.6%.
Undiagnosed and diagnosed diabetes
In general, the standardized prevalence of diabetes was
9% (men 7.7% and women 10.3%), of which 2.7% were
undiagnosed diabetes (men 2.8% vs women 2.6%) and
6.3% diagnosed (men 4.9% vs women 7.7%).
Undiagnosed DM was more prevalent in elderly indi-
viduals (6.8% among people aged 65–75 years), people
with primary-to-high school education (2.8%), non-
smokers (2.8%), opium dependent users (2.7%), people
without anxiety symptoms (3.2%), obese people (4%),
and those with positive familial history of DM (3.7%).
There was nearly an equal prevalence of undiagnosed-
DM in subpopulations regarding depression and physi-
cal activity.
The diagnosed-DM increased steadily from 1% in
young adult (age group 15–24) to 26.3% in elderly people
(aged 55–64 years). DM was diagnosed in 6.7% of (high
school and more) educated people. Compared to non-
cigarette smokers, prevalence of diagnosed-DM was
more in smokers (6.3% vs 9.1%). The prevalence of DM
was diagnosed in 7.0% of occasional opium users, while
it was 4.0% among dependent users. The diagnosed-DM
prevalence among individuals with depression and
anxiety symptoms was 7.3% and 6.6%, respectively.
Seven percent of overweight and 7.6% of obese people
had diagnosed-DM. In people with high physical activ-
ity, diagnosed-DM prevalence was at a minimum of
3.7%. Compared to subjects with negative familial
history of DM, people with positive history had higher
prevalence of diagnosed-DM (4.3% vs 10.0%).
Diabetes mismanagement: old definition
Overall, in people with diagnosed-DM, the prevalence of
uncontrolled DM was 76.5% (men 75.1% vs women
77.3%) (Table 2). The uncontrolled-DM increased from
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60% in young adults to 77.8% in elderly people. The
frequency of uncontrolled-DM among people without
and with (both insulin and non-insulin) treatment was
57.9% and 92.9%, respectively. Less educated people had
worse uncontrolled DM in comparison with highly edu-
cated individuals (78.1% vs 68.3%). Uncontrolled-DM
among non-smokers was higher than smokers (77.3% vs
70.5%). The frequency of uncontrolled-DM varied from
76.1% among non opium users to 81.3% in dependent
opium users. Among the diagnosed-DM people, 79.5%
of depressed and 75.5% of anxious people were identified
as uncontrolled-DM. Regarding obesity, uncontrolled-
DM ranged from 79.9% (normal BMI) to 72.7% (obese
subgroup). People with low physical activity had a higher
frequency of uncontrolled-DM (79.4%), which decreased
to 66.7% in people with high level of physical activity.
More than 74% of the diabetic patients who had positive
history of familial DM were uncontrolled.
Table 1 Standardized prevalence of pre-diabetes, undiagnosed and diagnosed diabetes, Community-Based Study (KERCADR – 1st Round:
n = 5895), Kerman, Iran, 2010–2011
Subgroups Normal Pre-diabetes
Diabetes
Undiagnosed Diagnosed
Overall 72.3 (70.8, 73.9) 18.7 (17.3, 20.1) 2.7 (2.3, 3.3) 6.3 (5.7, 6.9)
Sex
Men 68.8 (66.3, 71.2) 23.4 (21.2, 25.9) 2.8 (2.2, 3.6) 4.9 (4.2, 5.7)
Women 76.0 (74.2, 77.8) 13.7 (12.2, 15.3) 2.6 (2.1, 3.4) 7.7 (6.8, 8.7)
Age groups
15–24 83.7 (80.4, 86.5) 14.7 (12.0, 17.9) 0.7 (0.3, 1.6) 1.0 (0.4, 2.3)
25–34 81.2 (78.3, 83.9) 15.1 (12.7, 17.9) 1.8 (1.1, 3.0) 1.9 (1.1, 3.2)
35–44 68.3 (64.9, 71.5) 20.9 (18.2, 23.8) 4.9 (3.4, 6.9) 6.0 (4.5, 7.9)
45–54 53.2 (50.0, 56.5) 24.6 (21.8, 27.5) 4.8 (3.5, 6.4) 17.4 (15.1, 20.0)
55–64 42.0 (38.5, 45.5) 25.1 (22.2, 28.2) 6.7 (5.1, 8.7) 26.3 (23.3, 29.5)
65–75 40.9 (36.2, 45.7) 28.4 (24.2, 33.0) 6.8 (4.7, 9.8) 23.9 (20.0, 28.3)
Education
Illiterate 66.5 (50.9, 79.1) 25.9 (14.2, 42.5) 1.7 (1.1, 2.6) 6.0 (4.3, 8.2)
Primary to high school 72.9 (71.1, 74.7) 18.0 (16.4, 19.7) 2.8 (2.3, 3.5) 6.2 (5.5, 7.0)
Above high school 71.9 (68.7, 74.9) 19.5 (16.7, 22.6) 1.9 (1.2, 3.0) 6.7 (5.4, 8.2)
Current cigarette smoker
No 72.1 (70.4, 73.7) 18.8 (17.3, 20.4) 2.8 (2.3, 3.4) 6.3 (5.7, 7.0)
Yes 77.8 (71.4, 83.1) 11.5 (9.3, 14.0) 1.6 (1.0, 2.7) 9.1 (4.9, 16.3)
Opium addiction
No 72.4 (70.7, 74.0) 18.6 (17.1, 20.1) 2.6 (2.1, 3.2) 6.4 (5.8, 7.1)
Occasional user 56.8 (49.6, 63.7) 34.6 (28.1, 41.8) 1.5 (0.8, 2.7) 7.0 (5.1, 9.6)
Dependent user 60.0 (53.9, 65.8) 15.4 (10.4, 22.2) 2.7 (1.5, 5.0) 4.0 (2.9, 5.4)
Depression
No 71.9 (70.0, 73.7) 19.6 (17.9, 21.4) 2.8 (2.2, 3.4) 5.7 (5.0, 6.4)
Yes 74.8 (72.2, 77.2) 15.2 (13.1, 17.6) 2.7 (1.9, 3.6) 7.3 (6.1, 8.7)
Anxiety
No 72.8 (69.5, 75.9) 19.1 (16.3, 22.2) 3.2 (2.3, 4.4) 5.5 (4.1, 6.1)
Yes 72.5 (70.7, 74.2) 18.4 (16.8, 20.1) 2.5 (2.0, 3.2) 6.6 (5.9, 7.3)
Obesity
Normal 76.9 (74.9, 78.8) 16.1 (14.4, 17.9) 1.8 (1.3, 2.5) 5.2 (4.4, 6.2)
Overweight 67.6 (63.9, 71.1) 22.1 (18.9, 25.8) 3.2 (2.5, 4.2) 7.0 (6.0, 8.2)
Obese 68.3 (63.2, 73.0) 20.1 (16.0, 25.1) 4.0 (2.4, 6.4) 7.6 (6.2, 9.2)
Physical activity
Low 70.4 (67.7, 72.9) 20.5 (18.2, 23.0) 2.6 (2.0, 3.4) 6.5 (5.6, 7.5)
Moderate 72.7 (70.4, 74.9) 18.1 (16.1, 20.3) 2.8 (2.2, 3.7) 6.4 (5.6, 7.2)
High 77.8 (73.2, 81.9) 15.2 (11.7, 19.5) 3.2 (1.9, 5.4) 3.7 (2.3, 5.8)
Family History of DM
No 75.3 (73.5, 77.1) 18.0 (16.4, 19.8) 2.3 (1.8, 2.9) 4.3 (3.8, 5.0)
Yes 66.7 (63.6, 69.7) 19.6 (17.0, 22.5) 3.7 (2.8, 4.9) 10.0 (8.6, 11.6)
DM, diabetes mellitus; numbers are reported as % and (95% confidence interval).
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New definition
With the new definition (details are mentioned above in
the method), the overall uncontrolled-DM was observed
in 60.8% of the diagnosed DM cases (men 59.7% vs
women 61.5%). Using the new definition, the prevalence
of uncontrolled-DM decreased by 7% to 30% in different
subpopulations. The biggest difference was observed in
the elderly group (47.5%), those receiving insulin therapy
(69.6%), illiterate (48.2%), Opium dependent users
(62.5%), people with depression symptoms (60.4%) and
those with no familial history of DM (60.3%).
Predictors of diabetes
In crude analysis, sex (male vs female), age, education,
opium addiction, depression, increased BMI category,
lower physical activity, and DM familial history turned
to be potential significant predictors for DM (Table 3).
While in the multivariate model, after removing con-
founding effects, it was shown that the odds of diabetes
increased significantly only by age group (AOR 5.0 to
18.2), depression (AOR 1.2), overweight and obesity
(AOR 1.6, and 1.5), moderate and low physical activity,
(AOR 1.5, and 1.4) and the positive familial history of
DM (AOR 2.2). The other variables did not have a sta-
tistically significant association with diabetes.19
Diabetes-related co-morbidities
The maximum prevalence of co-morbidities among
patients with diagnosed DM were anxiety (87.5%),
depression (57.9%) and overweight/obesity (47.1%);
among people with undiagnosed DM, most frequent
co-morbidities were again anxiety (73.2%) and
overweight/obesity (55.6%) while hypercholesterolemia
(54.3%) also become very common, too (Table 4).
Among individuals with pre-diabetes, again anxiety
(76.2%), overweight/obesity (50.5%) and hypercholester-
olemia (35.4%) were the most frequent co-morbidities.
The least frequent co-morbidity was hypertension (9.4%
to 17.1%).
Sex and age interacted on diabetes
The standardized prevalence of diabetes was almost
comparable in men and women by age of 45 years
(Fig. 1). In comparison to the trend observed for
younger people, the DM prevalence significantly
increased at about 40 years in both sexes, while later,
women disproportionately turned out to be diabetic in
comparison to men. DM prevalence peaked in men
(33.8%) at age of 60–64 years and in women (38.9%) at
age of 65–69 years and then started to decrease.
Discussion
In our analysis, we found one out of four individuals
living in an urban area in Iran either had impaired
glucose level (pre-diabetes) or diabetes. Near to 3% of
individuals had their diabetes undiagnosed and in more
Table 2 Prevalence of control and un-controlled diabetes among
diagnosed diabetic patients (n = 536), Community-Based Study
(KERCADR – 1st Round: n = 5895), Kerman, Iran, 2010–2011
Subgroups
Uncontrolled diabetes
Old definition New definition
Overall 76.5 (72.7, 79.9) 60.8 (56.6, 64.9)
Sex
Men 75.1 (68.7, 80.6) 59.7 (52.8, 66.2)
Women 77.3 (72.5, 81.5) 61.5 (56.2, 66.6)
Age groups
15–34 60.0 (34.8, 80.8) 60.0 (34.8, 80.8)
35–44 59.5 (43.2, 73.9) 59.5 (43.2, 73.9)
45–54 77.7 (70.6, 83.5) 70.1 (62.6, 76.6)
55–64 77.8 (71.4, 83.1) 60.8 (53.7, 67.5)
65–75 77.8 (68.5, 85.0) 47.5 (37.9, 57.2)
DM Treatment
None 57.9 (48.7, 66.6) 44.7 (35.9, 53.9)
Non-insulin 80.1 (75.7, 83.9) 63.8 (58.8, 68.6)
Insulin 89.1 (76.4, 95.4) 69.6 (54.9, 81.1)
Insulin and non-insulin 92.9 (62.7, 99.0) 85.7 (56.9, 96.5)
Education
Illiterate 78.1 (70.4, 84.3) 48.2 (39.9, 56.6)
Primary to high school 77.3 (72.6, 81.4) 65.8 (60.6, 70.7)
Above high school 68.3 (55.6, 78.8) 61.7 (48.9, 73.0)
Current cigarette smoker
No 77.3 (73.3, 80.8) 61.1 (56.5, 65.4)
Yes 70.5 (58.2, 80.4) 59.0 (46.6, 70.4)
Opium addiction
No 76.1 (72.0, 79.9) 60.1 (55.3, 64.7)
Occasional user 74.5 (60.9, 84.6) 64.7 (50.8, 76.5)
Dependent user 81.3 (67.7, 89.9) 62.5 (48.2, 74.9)
Depression
No 72.9 (67.1, 78.0) 61.8 (55.6, 67.5)
Yes 79.5 (74.4, 83.8) 60.4 (54.5, 66.0)
Anxiety
No 78.3 (69.5, 85.1) 63.2 (53.8, 71.7)
Yes 75.9 (71.7, 79.7) 60.5 (55.8, 65.1)
Obesity
Normal 79.9 (72.7, 85.5) 66.4 (58.6, 73.5)
Overweight 77.2 (71.5, 82.0) 59.8 (53.5, 65.7)
Obese 72.7 (64.7, 79.4) 59.0 (50.4, 67.0)
Physical activity
High 66.7 (44.7, 83.2) 57.1 (36.0, 76.0)
Moderate 74.4 (68.7, 79.4) 59.7 (53.6, 65.5)
Low 79.4 (74.0, 83.9) 62.3 (56.1, 68.0)
Family History DM
No 78.6 (72.8, 83.4) 60.3 (53.8, 66.4)
Yes 74.4 (69.0, 79.1) 59.9 (54.1, 65.4)
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than 60% of diagnosed diabetic patients, the treatment
was not effective.
In comparison to an International Diabetes Federa-
tion (IDF) report 2011 on the global prevalence of dia-
betes (8.3%), we observed a slightly greater prevalence
(9%) of diabetes in our study population. However, we
found that 23.4% of men and 13.7% of women were at
the pre-diabetes stage. This should be taken as an
opportunity by health authorities to prevent more dia-
betic cases and burden of disease. It has been shown
that by losing weight and increasing physical activity,
individuals can prevent or delay pre-diabetes from pro-
gressing to diabetes.9–12
The prevalence of diabetes was almost comparable
among men and women by the age of 40 years when it
started to increase considerably in both sexes, particu-
larly among women. In several studies, it has been
reported that the prevalence of diabetes (diagnosed and
undiagnosed), impaired glucose tolerance (IGT) and
impaired fasting glucose (IFG) increased by age13–15 is
not similar between men and women.13 Such differential
increase among women can be partly explained by the
higher prevalence of obesity16–18 and low physical activ-
ity for work and transportation, in recent published
studies.9–12 Hadaegh et al. found that the prevalence of
IFG increased by age only among women.13 The reduc-
tion in the prevalence of diabetes among individuals
aged 65 or more found in the current study could be
due to the higher mortality in diabetic patients in com-
parison to the rest of the population, since diabetes also
has been reported as a trigger for other cardiovascular
diseases such as acute myocardial infarction.19
Although we have measured and reported the preva-
lence of diabetes (not incidence), the observed trend of
diabetes by age indicated both onset and mortality were
occurring in Iran at earlier ages (less than 40 years and 65
years, respectively) in comparison to global and devel-
oped countries’ trends.2,3 The underlying factors need to
be fully explored in future studies, but generally, increas-
ing trend was also observed for unhealthy diet,20,21 low
physical activity,22,23 and overweight and obesity16–18 in
the Iranian population.
Regarding the effect of cigarette smoking and opium
consumption, the results of this study showed almost no
statistically significant effects on control of diabetes or
odds ratio of predictors of diabetes (Tables 2,3).
However, based on the effect on some other risk factors
such as the increase in basal mean arterial pressure and
low-density lipoprotein/high-density lipoprotein (LDL/
HDL) ratio,24 increase in prevalence of high systolic
blood pressure and reduction in HDL,25 and more ECG
abnormalities found in long term opium exposure,26 the
findings are in contrast to the belief of many opium
consumers in Iran that opium may have an ameliorating
effect on diabetes or other CVD risk factors.
It seems that basic preventive measures for such pre-
ventable risk factors are overlooked by health authorities
and also the people themselves in urban areas. In rural
areas, Iran has a well-developed primary health-care
system, having Behvarz workers responsible for
population-based prevention and control services. The
effect of Behvarz workers in rural areas on better diabe-
tes management (both diagnosis and treatment) has been
acknowledged in a recent published paper.5
Table 3 Crude and adjusted odds ratio for different predictors of
diabetes mellitus, Community-Based Study (KERCADR – 1st Round:
n = 5895), Kerman, Iran, 2010–2011
Subgroups Crude OR Adjusted OR
Sex
Men 1 1
Women 1.3 (1.1, 1.5) 1.2 (0.9, 1.4)
Age groups
15–24 1 1
25–34 2.3 (1.1, 4.7) 1.8 (0.8, 3.7)
35–44 7.3 (3.7, 14.3) 5.0 (2.5, 10.0)
45–54 17.1 (8.9, 32.7) 11.7 (6.0, 22.9)
55–64 29.4 (15.5, 56) 20.7 (10.6, 40.6)
65–75 26.6 (13.7, 51.7) 18.2 (9.0, 36.4)
Education
Illiterate 1 1
Primary to high school 0.4 (0.3, 0.5) 0.8 (0.6, 1.0)
Above high school 0.4 (0.3, 0.5) 0.8 (0.6, 1.1)
Current cigarette smoker
No 1
Yes 0.9 (0.7, 1.2)
Opium addiction
No 1 1
Occasional user 1.4 (1.1, 1.9) 1.2 (0.9, 1.7)
Dependent user 1.2 (0.9, 1.5) 0.9 (0.7, 1.3)
Depression
No 1 1
Yes 1.6 (1.4, 1.9) 1.2 (1.0, 1.4)
Anxiety –
No 1
Yes 1.1 (0.9, 1.3)
BMI
Normal 1 1
Overweight 2.3 (1.9, 2.7) 1.6 (1.3, 2.0)
Obese 2.5 (2.1, 3.2) 1.5 (1.2, 2.0)
Physical activity
High 1 1
Moderate 2.1 (1.5, 3.0) 1.5 (1.0, 2.2)
Low 2.2 (1.5, 3.1) 1.4 (1.0, 2.1)
Family History DM
No 1 1
Yes 2.1 (1.8, 2.5) 2.2 (1.8, 2.6)
OR, odds ratio; numbers are reported as odds ratio (OR) and (95%
confidence interval).
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However, in urban areas, patients’ compliance with
medication and regular visits to physicians depends on
the patients themselves. To cover this gap in primary
health-care in urban settings, the family physician
program has been piloted in a few cities and now
expanded to many urban areas in Iran.27,28 However, at
the time of the study, such services were not available to
the population. Our findings provided the baseline status
of diabetes treatment/management while the effect of
such interventions should be monitored over time by
the next phase of the KERCADRs study or other
population-based surveys.
We should acknowledge the limitations of our study.
The main limitation of our analysis to assess the effec-
tiveness of diabetes management was the use of preva-
lence data. Like other cross-sectional studies, our
findings are prone to be distorted by surveillance bias
and reverse causality. We also were not able to distin-
guish type I from II diabetes as we did not review indi-
vidual’s medical records. Near to 200 patients with
impaired FPG level did not return for HbA1c test. On
average, they had lower FPG (−1.98 mmol/L) in com-
parison to those who returned and tested for HbA1c.
Although they were small in size, compared to the total
recruited people, the prevalence of uncontrolled diabetes
might be partly overestimated due to such selection bias.
In conclusion, we found that diabetes and susceptibil-
ity in to diabetes was very common in Kerman. The
prevalence increased by age, particularly after 40 years.
A considerable number of people had their diabetes
undiagnosed, while in those who have been diagnosed
with diabetes, the treatment was not effective and more
than 60% presented with impaired HbA1c test results.
Like rural areas, more feasible interventions at the
primary health-care in urban areas for early diagnosis
and better management of diabetic cases is needed to
prevent further morbidity and mortality of diabetes in
Iran.
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